Intrinsic Value

The intrinsic value of Ion Beam Applications SA (IOBCF) under the Base Case is 19.61 USD per share. Compared with the current market price of 18.5 USD, the stock appears Undervalued by 6% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

IOBCF Intrinsic Value
$19.61
Undervaluation 6%
Intrinsic Value
Price $18.5
Alert me when IOBCF is below its intrinsic value
Today $15.69 · 15.2% below the current price

IOBCF is valued in line with its history. A discount of this size has been typical over the past 5 years.

Alternatives to IOBCF

Fundamental Analysis

What Ion Beam Applications Does

Health Care

Ion Beam Applications, or IBA, builds and services particle accelerator systems, best known for proton therapy equipment used to treat cancer. The company also makes industrial accelerators used in applications such as sterilizing medical products, inspecting materials, and other precision radiation processes. In simple terms, IBA sells the complex machines and the technical support needed to install, run, and maintain them.

Headquarters
Belgium BE
Employees
2 039
IPO date
Jun 13, 1998
Read the full company overview
View Company Overview

Ion Beam Applications has no economic moat

No Moat Narrow Wide

Ion Beam Applications SA lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.

Read the full moat analysis
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue IOBCF Research

Decided on Ion Beam Applications? Get an email when IOBCF reaches the price you’d buy at. Free with an account.

Other Ion Beam Applications listings

What is the Intrinsic Value of one IOBCF stock?

The intrinsic value for Ion Beam Applications SA (IOBCF) under the Base Case is 19.61 USD.

Is IOBCF stock undervalued or overvalued?

Compared with the current market price of 18.5 USD, the stock appears Undervalued by 6% .

How reliable are our estimates? See how past valuations played out
Back to Top